Gene · 2248
Papers2,103
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 2,103
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- and Intra-tumoral Heterogeneity. | Cell | 2020 | 31883794 | PubTator, text mining | PubMed |
| Comparative study on the mutational profile of adenocarcinoma and squamous cell carcinoma predominant histologic subtypes in Chinese non-small cell lung cancer patients. | Thorac Cancer | 2020 | 31692283 | PubTator, text mining | PubMed |
| A multicenter analysis of genomic profiles and PD-L1 expression of primary lymphoepithelioma-like carcinoma of the lung. | Mod Pathol | 2020 | 31659278 | PubTator, text mining | PubMed |
| A Single-Step, High-Dose Selection Scheme Reveals Distinct Mechanisms of Acquired Resistance to Oncogenic Kinase Inhibition in Cancer Cells. | Cancer Res | 2020 | 31641034 | PubTator, text mining | PubMed |
| Mapping the binding sites of antibodies utilized in programmed cell death ligand-1 predictive immunohistochemical assays for use with immuno-oncology therapies. | Mod Pathol | 2020 | 31558782 | PubTator, text mining | PubMed |
| Biomarkers of Targeted Therapy and Immuno-Oncology in Cancers Metastatic to the Breast. | Appl Immunohistochem Mol Morphol | 2020 | 31517642 | PubTator, text mining | PubMed |
| Growth factor and receptor malfunctions associated with human genetic deafness. | Clin Genet | 2020 | 31506927 | PubTator, text mining | PubMed |
| Entrectinib resistance mechanisms in ROS1-rearranged non-small cell lung cancer. | Invest New Drugs | 2020 | 31124056 | PubTator, text mining | PubMed |
| Building an Artificial Stem Cell Niche: Prerequisites for Future 3D-Formation of Inner Ear Structures-Toward 3D Inner Ear Biotechnology. | Anat Rec (Hoboken) | 2020 | 30635991 | PubTator, text mining | PubMed |
| Genomic and Immune Profiling of a Patient With Triple-Negative Breast Cancer That Progressed During Neoadjuvant Chemotherapy Plus PD-L1 Blockade. | JCO Precis Oncol | 2019 | 32914041 | PubTator, text mining | PubMed |
| "False Patellar Duplication" Originated from Synovial Osteochondromatosis in Knee Joint: A Rare Case Report. | Open Access Maced J Med Sci | 2019 | 32215092 | PubTator, text mining | PubMed |
| Tertiary amine-directed and involved carbonylative cyclizations through Pd/Cu-cocatalyzed multiple C-X (X = H or N) bond cleavage. | Chem Sci | 2019 | 32055315 | PubTator, text mining | PubMed |
| Recent Advances in Meningioma Immunogenetics. | Front Oncol | 2019 | 31970090 | PubTator, text mining | PubMed |
| Control of Intracellular Molecular Networks Using Algebraic Methods. | Bull Math Biol | 2019 | 31919596 | PubTator, text mining | PubMed |
| Phase 1 Dose Escalation Study of the Allosteric AKT Inhibitor BAY 1125976 in Advanced Solid Cancer-Lack of Association between Activating AKT Mutation and AKT Inhibition-Derived Efficacy. | Cancers (Basel) | 2019 | 31835495 | PubTator, text mining | PubMed |
| Clinical Implications of Sub-grouping HER2 Positive Tumors by Amplicon Structure and Co-amplified Genes. | Sci Rep | 2019 | 31827209 | PubTator, text mining | PubMed |
| Past, Present and Future of Flow Cytometry in Breast Cancer - A Systematic Review. | EJIFCC | 2019 | 31814815 | PubTator, text mining | PubMed |
| Phenotypic Screen with the Human Secretome Identifies FGF16 as Inducing Proliferation of iPSC-Derived Cardiac Progenitor Cells. | Int J Mol Sci | 2019 | 31801200 | PubTator, text mining | PubMed |
| HSV-1 triggers paracrine fibroblast growth factor response from cortical brain cells via immediate-early protein ICP0. | J Neuroinflammation | 2019 | 31791351 | PubTator, text mining | PubMed |
| Expression and role of HEPIS in breast cancer. | Oncol Lett | 2019 | 31788121 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2248/papers?page=46